Krensavage Asset Management, LLC 13F holdings, Q3 2024
Holdings as of September 30, 2024 · filings on SEC EDGAR · latest filing →
Krensavage Asset Management, LLC disclosed 13 US equity positions worth $178.5m in its Q3 2024 13F filing. The largest position was UTHR at 20.1% of the reported book, followed by EXEL and CAH.
What did Krensavage Asset Management, LLC own in Q3 2024? Top 13 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs prior |
|---|---|---|---|---|---|---|---|
| 1 | UTHR UNITED THERAPEUTICS CORP | Healthcare | 20.1% | $36.0m | 100,332 | – | |
| 2 | EXEL EXELIXIS INC | Healthcare | 18.6% | $33.3m | 1,281,612 | – | |
| 3 | CAH CARDINAL HEALTH INC | Healthcare | 13.0% | $23.2m | 210,263 | – | |
| 4 | BIIB BIOGEN INC | Healthcare | 12.3% | $22.0m | 113,502 | – | |
| 5 | ENTA ENANTA PHARMACEUTICALS INC | Healthcare | 8.7% | $15.5m | 1,498,074 | – | |
| 6 | JAZZ JAZZ PHARMACEUTICALS PLC | Healthcare | 6.9% | $12.3m | 110,257 | – | |
| 7 | BNTX BIONTECH SE-ADR | Healthcare | 6.2% | $11.1m | 93,583 | – | |
| 8 | SNY SANOFI-ADR | 4.9% | $8.7m | 150,205 | – | ||
| 9 | ALKS ALKERMES PLC | Healthcare | 3.9% | $7.0m | 251,495 | – | |
| 10 | INDIVIOR PLC | 3.8% | $6.8m | 701,873 | – | ||
| 11 | VNDA VANDA PHARMACEUTICALS INC | Healthcare | 1.1% | $1.9m | 414,684 | – | |
| 12 | REGN REGENERON PHARMACEUTICALS | Healthcare | 0.2% | $371.0k | 353 | – | |
| 13 | MURAL ONCOLOGY PLC | 0.1% | $237.0k | 75,868 | – |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.